Aura Biosciences IPO

aurabiosciences.com

Aura Biosciences is a biotechnology company developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed.

Founded2009
Total Funding to Date$225.08MM
Register for Details

For more details on financing and valuation for Aura Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Aura Biosciences Ticker Symbol

Aura Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Aura Biosciences Stock Price

The stock price for Aura Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Aura Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/22/2021 Series E $283.03MM $XXX.XX $XXX.XX
7/9/2020 Series D-2 $157.27MM $XXX.XX $XXX.XX
4/2/2019 Series D-1 $139.53MM $XXX.XX $XXX.XX
12/21/2017 Series C-1 and C-2 $73.09MM $XXX.XX $XXX.XX
3/5/2015 Series B $50.26MM $XXX.XX $XXX.XX
8/17/2014 Series A-2 $22.08MM $XXX.XX $XXX.XX
7/4/2013 Series A-1 $29.11MM $XXX.XX $XXX.XX
8/26/2011 Series A $16MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Aura Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM